Does whole genome sequencing circumvent gene patents?

 What happens when, during the course of whole-genome sequencing (WGS) a patient or research subject, an investigator sequences and analyzes a disease gene that has been patented? The U.S. Supreme Court will shed some light on this question next year when it issues its ruling in the long-running Myriad Genetics saga. 

View the original article here: Does Whole Genome Sequencing Circumvent Gene Patents?

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-11-16-at-2.37.32-PM
30 years of GMO farming: Is the boom in glyphosate and glufosinate use harming the environment? Data show they’re the most sustainable choice
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Soybean Harvest in Cupped Hands
30 years of GMO farming: Defying cynics, we’ve had larger harvests, lower costs, and $385 billion in added global farmer income
Stormlit Portrait Over Golden Mountains
Searching for life where no one thought to look: A renowned astrophysicist’s seemingly quixotic quest to explore Venus’s clouds
Screenshot-2026-11-19-at-7.23.23-PM
Viewpoint: After a yearlong hiatus, the U.S. Preventive Services Task Force is back in business—gutted by RFK Jr. and promoting junk science
Screenshot-2026-11-19-at-7.54.57-PM
European General Court sides with scientists, dismisses activist claims that glyphosate is toxically dangerous
Nurturing Care Beneath the Crunchy Moms Logo
Crunchy Moms disinformation flood: Zuckerberg's Facebook has opened floodgates on measles and vaccines
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.